The Cancer Biopsy Market is estimated to be valued at US$ 22.86 Bn in 2022 and is expected to exhibit a CAGR of 14.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Cancer biopsy refers to the procedure of extracting and examining a sample of tissue or cells from a suspected tumor to determine the presence of cancer. It...